OTCMKTS:GTBIF FY2025 EPS Estimate Cut by Atb Cap Markets

Key Points

• Atb Cap Markets has revised its FY2025 earnings per share (EPS) estimate for Green Thumb Industries from $0.11 to $0.08, indicating reduced expectations for the company’s performance.
• In its most recent earnings report, Green Thumb Industries reported a net loss of ($0.01) per share, missing the consensus estimate of a $0.04 profit by $0.05.
• The company generated $293.26 million in revenue for the quarter, surpassing analyst expectations of $280.66 million despite the earnings shortfall.

Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Equities research analysts at Atb Cap Markets lowered their FY2025 EPS estimates for Green Thumb Industries in a research report issued to clients and investors on Thursday, August 7th. Atb Cap Markets analyst F. Gomes now expects that the company will earn $0.08 per share for the year, down from their previous estimate of $0.11. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share.

Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). The firm had revenue of $293.26 million during the quarter, compared to analyst estimates of $280.66 million. Green Thumb Industries had a net margin of 2.51% and a return on equity of 1.62%.

Green Thumb Industries Price Performance

Shares of OTCMKTS:GTBIF opened at $6.91 on Friday. The business has a 50-day moving average of $5.66 and a two-hundred day moving average of $6.00. The firm has a market capitalization of $1.46 billion, a PE ratio of 62.82 and a beta of 1.18. Green Thumb Industries has a 12 month low of $4.63 and a 12 month high of $12.00.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.